Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Association of Definitive Pelvic Radiation Therapy With Survival Among Patients With Newly Diagnosed Metastatic Cervical Cancer.

Wang Y, Farmer M, Izaguirre EW, Schwartz DL, Somer B, Tillmanns T, Ballo MT.

JAMA Oncol. 2018 Sep 1;4(9):1288-1291. doi: 10.1001/jamaoncol.2018.2677. No abstract available.

PMID:
30054609
2.
3.

Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer.

Ning MS, Ahobila V, Jhingran A, Stecklein SR, Frumovitz M, Schmeler KM, Eifel PJ, Klopp AH.

Gynecol Oncol. 2018 Jan;148(1):132-138. doi: 10.1016/j.ygyno.2017.10.017. Epub 2017 Oct 28.

PMID:
29089122
4.

Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study.

Culp SH, Schellhammer PF, Williams MB.

Eur Urol. 2014 Jun;65(6):1058-66. doi: 10.1016/j.eururo.2013.11.012. Epub 2013 Nov 20.

PMID:
24290503
5.

Radiation therapy for pelvic lymph node metastasis from uterine cervical cancer.

Hata M, Koike I, Miyagi E, Numazaki R, Asai-Sato M, Kasuya T, Kaizu H, Matsui T, Hirahara F, Inoue T.

Gynecol Oncol. 2013 Oct;131(1):99-102. doi: 10.1016/j.ygyno.2013.07.085. Epub 2013 Jul 19.

PMID:
23877014
6.

Pelvic fractures after definitive and postoperative radiotherapy for cervical cancer: A retrospective analysis of risk factors.

Yamamoto K, Nagao S, Suzuki K, Kogiku A, Senda T, Yano H, Kitai M, Shiozaki T, Matsuoka K, Yamaguchi S.

Gynecol Oncol. 2017 Dec;147(3):585-588. doi: 10.1016/j.ygyno.2017.09.035. Epub 2017 Oct 18.

PMID:
29055558
7.

Acute lower extremity paralysis following radiation therapy for cervical cancer.

Abu-Rustum NR, Rajbhandari D, Glusman S, Massad LS.

Gynecol Oncol. 1999 Oct;75(1):152-4.

PMID:
10502444
8.

Debulking metastatic pelvic nodes before radiotherapy in cervical cancer patients: a long-term follow-up result.

Cheung TH, Lo KW, Yim SF, Yau SH, Yu MM, Yeung WK.

Int J Clin Oncol. 2011 Oct;16(5):546-52. doi: 10.1007/s10147-011-0225-3. Epub 2011 Mar 25.

PMID:
21437570
9.

Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer.

Kidd EA, Siegel BA, Dehdashti F, Grigsby PW.

Cancer. 2010 Mar 15;116(6):1469-75. doi: 10.1002/cncr.24972.

10.

Insufficiency fractures after pelvic radiation therapy for uterine cervical cancer: an analysis of subjects in a prospective multi-institutional trial, and cooperative study of the Japan Radiation Oncology Group (JAROG) and Japanese Radiation Oncology Study Group (JROSG).

Tokumaru S, Toita T, Oguchi M, Ohno T, Kato S, Niibe Y, Kazumoto T, Kodaira T, Kataoka M, Shikama N, Kenjo M, Yamauchi C, Suzuki O, Sakurai H, Teshima T, Kagami Y, Nakano T, Hiraoka M, Mitsuhashi N, Kudo S.

Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):e195-200. doi: 10.1016/j.ijrobp.2012.03.042. Epub 2012 May 12.

PMID:
22583605
11.

Clinical response of pelvic and para-aortic lymphadenopathy to a radiation boost in the definitive management of locally advanced cervical cancer.

Rash DL, Lee YC, Kashefi A, Durbin-Johnson B, Mathai M, Valicenti R, Mayadev JS.

Int J Radiat Oncol Biol Phys. 2013 Oct 1;87(2):317-22. doi: 10.1016/j.ijrobp.2013.06.2031. Epub 2013 Jul 29.

PMID:
23906933
12.

Radiation Therapy for Patients with Bone Metastasis from Uterine Cervical Cancer: Its Role and Optimal Radiation Regimen for Palliative Care.

Hata M, Koike I, Miyagi E, Asai-Sato M, Kaizu H, Mukai Y, Takano S, Ito E, Sugiura M, Inoue T.

Anticancer Res. 2018 Feb;38(2):1033-1040.

PMID:
29374737
13.

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.

Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM, Mutch DG.

N Engl J Med. 1999 Apr 15;340(15):1137-43.

14.

Pelvic bone complications after radiation therapy of uterine cervical cancer: evaluation with MRI.

Kwon JW, Huh SJ, Yoon YC, Choi SH, Jung JY, Oh D, Choe BK.

AJR Am J Roentgenol. 2008 Oct;191(4):987-94. doi: 10.2214/AJR.07.3634.

PMID:
18806132
15.

Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.

Marconi DG, Fregnani JH, Rossini RR, Netto AK, Lucchesi FR, Tsunoda AT, Kamrava M.

BMC Cancer. 2016 Jul 28;16:556. doi: 10.1186/s12885-016-2619-0.

16.

Local Therapy Improves Overall Survival in Patients With Newly Diagnosed Metastatic Prostate Cancer.

Parikh RR, Byun J, Goyal S, Kim IY.

Prostate. 2017 May;77(6):559-572. doi: 10.1002/pros.23294. Epub 2017 Jan 17.

PMID:
28093791
17.

The impact of pre-therapy extraperitoneal surgical staging on the evaluation and treatment of patients with locally advanced cervical cancer.

Odunsi KO, Lele S, Ghamande S, Seago P, Driscoll DL.

Eur J Gynaecol Oncol. 2001;22(5):325-30.

PMID:
11766731
18.

Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.

Monk BJ, Cha DS, Walker JL, Burger RA, Ramsinghani NS, Manetta A, DiSaia PJ, Berman ML.

Gynecol Oncol. 1994 Jul;54(1):4-9.

PMID:
8020837
19.

Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.

Ho JC, Allen PK, Bhosale PR, Rauch GM, Fuller CD, Mohamed AS, Frumovitz M, Jhingran A, Klopp AH.

Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):546-553. doi: 10.1016/j.ijrobp.2016.11.015. Epub 2016 Nov 17.

20.

[The rule of metastatic pelvic lymph node distribution in patients with early stage cervical carcinoma].

Zhang HY, Sheng XG, Zhong Y, Ma ZF, Ma YB, Liu NF, Chen YT, Wang YY.

Zhonghua Zhong Liu Za Zhi. 2008 Jun;30(6):452-5. Chinese.

PMID:
19024522

Supplemental Content

Support Center